Arkolith/Insider Trading/ORKA/Form 4

Agarwal Arjun

Senior Vice President, FinanceOruka Therapeutics, Inc. (ORKA) · full profile →Form 4 · filed Jun 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$128K
Net Open-Market Flow
-$128K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 22, 2026Sell(S)888$80.01$71K16K
Jun 22, 2026Sell(S)699$82.14$57K15K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000066) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML